Antibacterial agents in infections of the central nervous system.

被引:16
作者
Chowdhury, MH
Tunkel, AR
机构
[1] Med Coll Penn & Hahnemann Univ, Sch Med, Dept Med, Philadelphia, PA 19129 USA
[2] Med Coll Penn & Hahnemann Univ, Sch Med, Div Infect Dis, Philadelphia, PA 19129 USA
关键词
D O I
10.1016/S0891-5520(05)70254-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Animal models have been invaluable in our understanding of the use of antibacterial agents in the therapy of central nervous system (CNS) infections.(77) Although in vitro susceptibility testing may give information regarding the activity of an antibacterial agent against a bacterial pathogen, the in vivo effectiveness of a drug may be very different. The animal model of meningitis most frequently used for therapeutic studies at the present time is the rabbit model, which uses an intracisternal method for organism inoculation.(16) The intracisternal route of inoculation appears to be the most reliable method for producing experimental meningitis in animals, although there are several disadvantages: (1) the natural route of dissemination to the cerebrospinal fluid (CSF) is bypassed so the pathogenesis is artificial; (2) early bacteremia and death may supervene prior to CSF inflammation; (3) extravasation into the surrounding tissues may occur; (4) direct trauma to the medulla oblongata may result in cardiorespiratory arrest; and (5) anesthetics and analgesics used during experiments may alter the pathophysiology of meningitis by inducing hypotension, hypoventilation, or both. In addition, other predisposing conditions (e.g., history of head trauma, splenectomy, immunosuppression) that may be present in patients with meningitis are not taken into consideration in experimental models; these factors may have significant roles in the pathogenesis of bacterial meningitis.(39) Despite these disadvantages, the intracisternal route of inoculation in the rabbit model is preferred because of easy handling of the animals, relative inexpense, and sufficient CSF volume allows frequent sampling of CSF for quantitative antimicrobial and bacterial concentrations during the treatment period. This model also permits quantitation of the relative penetration of drug into CSF, the effects of meningitis on this entry parameter, and the relative bactericidal efficacy within purulent CSF.
引用
收藏
页码:391 / +
页数:19
相关论文
共 83 条
[51]  
ORYAN M, 1996, 36 INT C ANT AG CHEM, P284
[52]  
PELTOLA H, 1989, LANCET, V1, P1281
[53]   MORPHOLOGICAL ALTERATIONS OF THE BLOOD-BRAIN-BARRIER WITH EXPERIMENTAL MENINGITIS IN THE RAT - TEMPORAL SEQUENCE AND ROLE OF ENCAPSULATION [J].
QUAGLIARELLO, VJ ;
LONG, WJ ;
SCHELD, WM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (04) :1084-1095
[54]   RECURRENT LISTERIA-MONOCYTOGENES MENINGITIS TREATED WITH INTRAVENTRICULAR VANCOMYCIN [J].
RICHARDS, SJ ;
LAMBERT, CM ;
SCOTT, AC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (03) :351-353
[55]   Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model [J].
Rodoni, D ;
Hänni, F ;
Gerber, CM ;
Cottagnoud, M ;
Neftel, K ;
Täuber, MG ;
Cottagnoud, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :963-965
[56]   TREATMENT OF PSEUDOMONAS MENINGITIS WITH CEFTAZIDIME WITH OR WITHOUT CONCURRENT THERAPY [J].
RODRIGUEZ, WJ ;
KHAN, WN ;
COCCHETTO, DM ;
FERIS, J ;
PUIG, JR ;
AKRAM, S .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (02) :83-87
[57]  
RODRIGUEZCERRAT.V, 1999, 39 INT C ANT AG CHEM, P9
[58]   Antimicrobial and anti-inflammatory treatment of bacterial meningitis [J].
Sáez-Llorens, X ;
McCracken, GH .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1999, 13 (03) :619-+
[59]   PROSPECTIVE RANDOMIZED COMPARISON OF CEFEPIME AND CEFOTAXIME FOR TREATMENT OF BACTERIAL-MENINGITIS IN INFANTS AND CHILDREN [J].
SAEZLLORENS, A ;
CASTANO, E ;
GARCIA, R ;
BAEZ, C ;
PEREZ, M ;
TEJEIRA, F ;
MCCRACKEN, GH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) :937-940
[60]   EPIDEMIOLOGY AND MOLECULAR-BASIS OF PENICILLIN-RESISTANT NEISSERIA-MENINGITIDIS IN SPAIN - A 5-YEAR HISTORY (1985-1989) [J].
SAEZNIETO, JA ;
LUJAN, R ;
BERRON, S ;
CAMPOS, J ;
VINAS, M ;
FUSTE, C ;
VAZQUEZ, JA ;
ZHANG, QY ;
BOWLER, LD ;
MARTINEZSUAREZ, JV ;
SPRATT, BG .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (02) :394-402